Viracta Therapeutics
Why Robinhood?
You can watch VIRX and buy or sell other stocks, ETFs, and their options commission-free!About VIRX
Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas.
VIRX Key Statistics
Stock Snapshot
With a market cap of 388.7K, Viracta Therapeutics(VIRX) trades at $0.01. The stock has a price-to-earnings ratio of -0.01.
During the trading day, Viracta Therapeutics(VIRX) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Viracta Therapeutics(VIRX) stock has reached 0, versus its average volume of 491.85K.
The stock's 52-week range extends from a low of $0.01 to a high of $0.58.
The stock's 52-week range extends from a low of $0.01 to a high of $0.58.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.